Delivery Order SPE2DE24DA011-SPE2D626F59MH
- Not listed
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical devices, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain valued at $20,019.76 for Knotless 1.8 Fibertak Implant System products. The contract, awarded on January 12, 2026, with an ultimate completion date of January 15, 2026, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. This delivery order is issued under...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $2,580.06 for DX Knotless Fibertak Implant Kits. The award was issued on August 7, 2025, with an ultimate completion date of August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain, a defense-aligned federal agency. This delivery order was issued under Arthrex's existing Indefinite Delivery Contract (IDC...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,925.22 for a DX Knotless Fibertak Implant Kit on December 10, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain with a completion date of December 15, 2025. This delivery order utilizes a fixed-price contract with economic price adjustment terms and does not include a set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical devices and implants, was awarded a delivery order valued at $3,627.36 on December 30, 2025, for the Knotless 1.8 Fibertak Implant System. The award represents a fixed-price contract with economic price adjustment authority and carries an ultimate completion date of January 7, 2026. This delivery order was issued without set-aside designation and will be performed at the contractor's Naples, Florida...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $3,005.38 delivery order by the Defense Logistics Agency's Medical Supply Chain on April 24, 2025, for KL 1.8 Fibertak shoulder implant systems. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 8, 2025, with performance taking place in Naples, Florida. The award represents a task order under Arthrex's existing Indefinite Delivery...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on July 14, 2025, for the Knotless 1.8 Fibertak Implant System with a ceiling value of $3,630. This fixed-price delivery order with economic price adjustment is scheduled for completion by July 17, 2025, and will be performed in Naples, Florida. The award was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $6,408 on December 31, 2025, for the Knotless 1.8 Fibertak Implant System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and will be performed at the contractor's Naples facility. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in federal procurement. This...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $110,623.37 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. This fixed-price delivery order with economic price adjustment provisions is for a Fibertak shoulder bridging implant system and will be completed by August 5, 2025. The award represents a task order issued under Arthrex's existing single-award Indefinite...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $41,778.60 for DX Knotless Fibertak Implant Kits. This fixed-price delivery order with economic price adjustment was issued on August 4, 2025, with an ultimate completion date of August 7, 2025, and will be performed in Naples, FL. The award was made through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency, with no...
- The Defense Logistics Agency's Medical Supply Chain awarded Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, a $3,993.54 fixed-price delivery order with economic price adjustment for a Knotless 1.8 Fibertak Implant System on August 29, 2025. The delivery order, which does not utilize a set-aside designation, is scheduled for completion by September 4, 2025, and will be delivered to Naples, Florida. Arthrex is a global leader in minimally invasive orthopedic...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D626F59MHDelivery Order
Arthrex Inc., headquartered in Naples, Florida, was awarded a $2,778.00 fixed-price delivery order (Contract No. 4570835648) by the Defense Logistics Agency's Medical Supply Chain for a Knotless 1.8 Fibertak Implant System. The award was issued without set-aside designation on February 3, 2026, with an ultimate completion date of February 19, 2026. The contract represents a task order under Arthrex's broader Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and effective through September 2029. This master contract vehicle authorizes procurement of orthopedic products and surgical technologies supporting Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. Arthrex serves as the prime contractor on this delivery order with no identified subcontractors, delivering specialized orthopedic implant technology directly to federal healthcare operations. The Fibertak implant system represents part of Arthrex's extensive portfolio of shoulder reconstruction and joint repair products designed for military personnel and veterans requiring minimally invasive orthopedic surgical solutions. The award reflects Arthrex's established competitive position as a primary supplier of advanced orthopedic implants, surgical instruments, and biologics to the federal healthcare enterprise, with demonstrated capability to fulfill government requirements independently across multiple orthopedic surgical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/2/26 |